MedPath

Use of Local Anesthetic (0.25% Bupivacaine) for Pain Control in Pediatric Cardiac Catheterization

Phase 2
Completed
Conditions
Pain
Interventions
Drug: Standard of Care plus bupivacaine
Drug: Standard of Care
Registration Number
NCT01133119
Lead Sponsor
The Hospital for Sick Children
Brief Summary

In the Cardiac Diagnostic and Interventional Unit (CDIU) at the Hospital for Sick Children (SickKids), minimally invasive procedures are performed to diagnose and treat a variety of congenital heart defects. Procedures are performed under general anesthetic and involve inserting a catheter through the skin and into the femoral vein or artery in the groin. In addition, the use of local anesthetic as a pain control regimen just prior to the removal of femoral artery or vein sheaths is used by some but not all cardiac interventionalists. Local anesthetic is infiltrated near the sheath insertion site, at the end of the procedure while the child is under general anesthetic, with the goal of decreasing pain at the insertion site and promoting comfort in the post-operative period. The use of local anesthetic depends on the choice of the individual practitioner and is not currently a routine practice for all patients.

The investigators proposed research seeks to investigate whether the use of subcutaneous bupivacaine reduces pain levels in the post-operative period in children having cardiac catheterization procedures.

Detailed Description

A number of differences in pediatric cardiac catheterization procedures exist that limit the transferability of research findings from the adult literature. For example, the majority of pediatric cardiac catheterizations are performed under general anesthetic, and femoral sheaths are removed while under general anesthetic and at the end of the procedure. In contrast in adult clinical practice, procedures are not performed under general anesthetic, and femoral sheaths are removed when patients are awake and often 4 to 6 hours after the end of the procedure. These differences limit the ability to apply research findings in adults to pediatrics, warranting further study of the effects of local anesthetic on femoral site pain in children. As well, studies in adults have examined pain only up to 20 minutes after sheath removal. We seek to investigate the impact of bupivacaine up to 6 hours after cardiac catheterization in children.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
140
Inclusion Criteria
  1. Ages 7-18 years
  2. Scheduled for cardiac catheterization through the femoral artery and/or vein under general anesthetic
  3. Ability to speak and understand English
  4. No apparent cognitive impairments
Exclusion Criteria
  1. Known allergies to bupivacaine
  2. Impaired renal function
  3. Impaired hepatic function

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment Group 2Standard of Care plus bupivacaine-
Treatment Group 1Standard of Care-
Primary Outcome Measures
NameTimeMethod
Self-reported levels of painFor 6 hours after admission to the CDIU

The primary outcome measure is self-reported levels of pain using the Numerical Rating Scale (NRS). Patients will be asked to verbally rate the amount of femoral pain experienced between 0-10 on admission to CDIU recovery, and at 15 and 30 minutes, and 1, 2, 4, and 6 hours after admission.

We will be examining the change in pain scores over time as well as the total pain experienced by the paitents. These measures will be compared between the two treatment groups.

Secondary Outcome Measures
NameTimeMethod
Use of analgesics6 hours post-operatively

Intervention groups will be able to receive additional analgesia as needed, and the type and amount of medication received will be recorded by nursing staff

Use of a suture to close the femoral arteryPost-operatively

If used, this suture is removed post-operatively and may influence post-operative pain levels. We would like to record whether a suture was used and removed as part of our data collection.

Trial Locations

Locations (1)

The Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath